Article Sidebar

Submitted
4 November 2016
Accepted
4 November 2016
Published
15 November 2016
Download
PDF
Statistic
Read Counter : 21251 Download : 3820

Main Article Content

Abstract

Hemolysis, elevated liver enzyme, and low platelet count syndrome (HELLPs) is complication following severe preeclampsia which is one of the three leading causes of maternal mortality in Indonesia. The purpose of this study was to understand the prevalence, characteristics, and post-partum outcome of HELLPs patients who deliver in Dr. Soetomo Hospital in July 2012-June 2013. This study was observational-descriptive, cross sectional study. The population observed was the severe preeclampsia patients who deliver in Dr. Soetomo Hospital and have complete medical data in July 2012-June 2013. study subject taken by total sampling. HELLPs follow the 7% of severe preeclampsia patients. The maternal average age of HELLPs group was 30.2 (19-43), while in non-HELLPs was 30.8 (17-46). Most HELLPs patients were in the first and second pregnancy. The average of gestational age at labor in HELLPs was 33-34 weeks. Both in HELLPs and non-HELLPs most performed Cesarean Section delivery. No post-partum maternal mortality found in HELLPs, but 25% had stillbirth. The average of birth weight in HELLPs was 1994.4 g. First minute Apgar score >7 was 33.3% in HELLPs group. In conclusion, Most HELLPs patients were in the first and second pregnancy, while non-HELLPs were in first pregnancy. The average of gestational age at labor was lower in HELLPs group. Neonates mortality were higher in HELLPs group. The average of birth weight was lower in HELLPs group. First minute Apgar score > 7 was higher in non-HELLP group.

Keywords

HELLP syndrome prevalence maternal age gestational age parity mode of delivery post-partum outcome birth weight Apgar score

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
P, W. A., Ernawati, E., & Susanti, D. (2016). CHARACTERISTICS OF HELLP SYNDROME IN SEVERE PREECLAMPSIA PATIENTS IN DR. SOETOMO HOSPITAL SURABAYA. Folia Medica Indonesiana, 51(4), 272–276. https://doi.org/10.20473/fmi.v51i4.2858
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM (1999). Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. American Journal of Obstetric and Gynecology 180, 221-225
  2. Ahmed FA, et al (2007). HELLP syndrome, a clinical variant of pre-eclampsia. ANNALS 13, 158-161
  3. Audibert F, Friedman SA, Frangieh AY, Sibai BM (1996). Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzyme, and low platelets) syndrome. American Journal of Obstetrics and Gynecology 175, 460-464
  4. Baxter JK, Weinstein L (2004). HELLP syndrome: the state of the art. Obstetrics and Gynecological Survey 59, 838-845
  5. Benedetto C, Marozio L, Tancredi A, Picardo E, Nardolillo P, Tavella AM, Salton L (2011). Biochemistry of HELLP syndrome. Adv Clin Chem 53, 85-104
  6. Erkilinc S and Eyi EGY (2013). Adolescent pregnan-cies complicated by HELLP syndrome: clinical experience of 26 cases. The Journal of Gynecology-Obstetrics and Neonatology 10, 1643-1646
  7. Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y (2005). Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 59, 113-118
  8. Hanumanthappa M (2011). Clinical study of HELLP syndrome in preeclampsia and eclampsia. Dissertation. Mysore Medical College and study Institute, Mysore. Available from http://119.82.96. 198:8080/jspui/bitstream/123456789/4943/1/Hanumanthappa%20M.pdf. Accessed June 28, 2013
  9. Haram K, Svendsen E, Abildgaard U (2009). The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy and Childbirth 9, 8
  10. Khumsat R, Wongwananurak T, Boriboonhirunsarn D (2008). Incidence and Risk Factors of HELLP Syndrome in Thai Pregnant Women with Severe Pre-eclampsia. Thai Journal of Obtetrics and Gynaecology 16, 192-198
  11. Liu CM, Chang SD, Cheng PJ, Chao AS (2006). Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP syndrome and women with severe preeclampsia without HELLP. Journal of Obstetric and Gynaecology study 32, 550-558
  12. Martin D and Conrad KP (2000). Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta 21, 23-31
  13. The National Institute of Health (2010). Diagnosis and management of preeclampsia: an update. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC 2990902/ Accessed June 22, 2013.
  14. Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H (2006). Maternal outcome in HELLP syndrome requiring intensive care and management in a Turkish hospital. Sao Paulo Medical Journal 124, 85-89
  15. Padden MO (1999). HELLP syndrome: recognition and perinatal management. American Family Physician 60, 829-836
  16. Portis R, Jacobs MA, Skerman JH, Skerman EB (1997). HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) patophysiology and anesthetic considerations. AANA Journal 65, 37-47
  17. Roelofsen AC, van Pampus MG, Aarnoudse JG (2003). The HELLP-syndrome; maternal-fetal outcome and follow up infants. Journal Perinatal Medicine 31, 201-208
  18. Satpathy HK, Satpathy C, Frey D (2009). Review article: HELLP syndrome. J Obstet Gynecol India 59, 30-40
  19. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993). Maternal mrbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). American Journal of Obstetrics and Gynecology 169, 1000-1006
  20. Singhal N, Amin HJ, Pollard JK, Tough SC, Johnston DW, Clark DJ, Sauve R (2004). Maternal haemolysis, elevated liver enzymes and low platelets syndrome: perinatal and neurodevelopmental neonatal outcomes for infants weighing less than 1250 g. Journal of Paediatric and Child Health 40, 121-126
  21. Wang YQ, Wang J, Ye RH, Zhao YY (2010). Investigation of diagnosis and treatment of hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome: clinical analysis of 59 cases. Chin Med J (Engl) 123, 1273-1277
  22. Weinstein L (1982). Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 142, 159–167